×

Acorda CEO: Interested in therapy for diabetic pain

6:58 PM ET Thu, 1 Aug 2013

Acorda CEO Dr. Ron Cohen discusses his talks with the FDA about a clinical trial for stroke victims, and its work on developing a product for diabetic pain.